zyzzyva57
10-03-2006, 11:07 PM
http://www.thestreet.com/_tscs/funds/madmoneywrap/10312759.html
Cramer's staff is awful at picking small drug companies, so beware of this goody with his usual good story
The main problem is the FDA can stop and fail "arna" Phase III Clinical Drug Trial at any moment--It is not a given when a drug reaches this phase of testing passing is a given...Beware! I have the same basic story several times before and cannot recall one $ucce$$ (He should fire the staffers who research small drug makers)
"arris" is worth watching, because Cramer's staff is good with tech stocks
Cramer's staff is awful at picking small drug companies, so beware of this goody with his usual good story
The main problem is the FDA can stop and fail "arna" Phase III Clinical Drug Trial at any moment--It is not a given when a drug reaches this phase of testing passing is a given...Beware! I have the same basic story several times before and cannot recall one $ucce$$ (He should fire the staffers who research small drug makers)
"arris" is worth watching, because Cramer's staff is good with tech stocks